Literature DB >> 26953154

The phenotypic evolution of Pseudomonas aeruginosa populations changes in the presence of subinhibitory concentrations of ciprofloxacin.

Tina Wassermann1, Karin Meinike Jørgensen2, Karolina Ivanyshyn2, Thomas Bjarnsholt1,2, S M Hossein Khademi3, Lars Jelsbak3, Niels Høiby1,2, Oana Ciofu2.   

Abstract

Ciprofloxacin is a widely used antibiotic, in the class of quinolones, for treatment of Pseudomonas aeruginosa infections. The immediate response of P. aeruginosa to subinhibitory concentrations of ciprofloxacin has been investigated previously. However, the long-term phenotypic adaptation, which identifies the fitted phenotypes that have been selected during evolution with subinhibitory concentrations of ciprofloxacin, has not been studied. We chose an experimental evolution approach to investigate how exposure to subinhibitory concentrations of ciprofloxacin changes the evolution of P. aeruginosa populations compared to unexposed populations. Three replicate populations of P. aeruginosa PAO1 and its hypermutable mutant ΔmutS were cultured aerobically for approximately 940 generations by daily passages in LB medium with and without subinhibitory concentration of ciprofloxacin and aliquots of the bacterial populations were regularly sampled and kept at  - 80 °C for further investigations. We investigate here phenotypic changes between the ancestor (50 colonies) and evolved populations (120 colonies/strain). Decreased protease activity and swimming motility, higher levels of quorum-sensing signal molecules and occurrence of mutator subpopulations were observed in the ciprofloxacin-exposed populations compared to the ancestor and control populations. Transcriptomic analysis showed downregulation of the type III secretion system in evolved populations compared to the ancestor population and upregulation of denitrification genes in ciprofloxacin-evolved populations. In conclusion, the presence of antibiotics at subinhibitory concentration in the environment affects bacterial evolution and further studies are needed to obtain insight into the dynamics of the phenotypes and the mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26953154     DOI: 10.1099/mic.0.000273

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  A Screen for Antibiotic Resistance Determinants Reveals a Fitness Cost of the Flagellum in Pseudomonas aeruginosa.

Authors:  E A Rundell; N Commodore; A L Goodman; B I Kazmierczak
Journal:  J Bacteriol       Date:  2020-02-25       Impact factor: 3.490

2.  Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.

Authors:  Marwa N Ahmed; Andreas Porse; Ahmed Abdelsamad; Morten Sommer; Niels Høiby; Oana Ciofu
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

3.  Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.

Authors:  Marwa N Ahmed; Andreas Porse; Morten Otto Alexander Sommer; Niels Høiby; Oana Ciofu
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Enhanced Biosynthesis of Fatty Acids Contributes to Ciprofloxacin Resistance in Pseudomonas aeruginosa.

Authors:  Yu-Bin Su; Xi-Kang Tang; Ling-Ping Zhu; Ke-Xin Yang; Li Pan; Hui Li; Zhuang-Gui Chen
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

5.  Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.

Authors:  Emily V Davies; Chloe E James; Michael A Brockhurst; Craig Winstanley
Journal:  BMC Microbiol       Date:  2017-01-05       Impact factor: 3.605

6.  Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets.

Authors:  Moawia M Al-Tabakha; Khairi M S Fahelelbom; Dana Emad Eddin Obaid; Sadik Sayed
Journal:  Pharmaceutics       Date:  2017-05-20       Impact factor: 6.321

7.  Evolution of high-level resistance during low-level antibiotic exposure.

Authors:  Erik Wistrand-Yuen; Michael Knopp; Karin Hjort; Sanna Koskiniemi; Otto G Berg; Dan I Andersson
Journal:  Nat Commun       Date:  2018-04-23       Impact factor: 14.919

8.  Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides.

Authors:  Lydia C Powell; Manon F Pritchard; Elaine L Ferguson; Kate A Powell; Shree U Patel; Phil D Rye; Stavroula-Melina Sakellakou; Niklaas J Buurma; Charles D Brilliant; Jack M Copping; Georgina E Menzies; Paul D Lewis; Katja E Hill; David W Thomas
Journal:  NPJ Biofilms Microbiomes       Date:  2018-06-29       Impact factor: 7.290

Review 9.  Ecological and Evolutionary responses to Antibiotic Treatment in the Human Gut Microbiota.

Authors:  Joseph Hugh Pennycook; Pauline Deirdre Scanlan
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

Review 10.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.